Biotechnology Stocks I Performance Guide: Exelixis, Inc. (EXEL)
EXEL has no dividends.
Table and Chart of EXEL Performance
See what a $1,000 investment in EXEL is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| EXEL Returns | |
|---|---|
| Start Date | Oct-31-2014 |
| Start Price | $1.70 |
| End Date | Oct-11-2024 |
| End Price | $26.23 |
| # Prices | 121 |
| Min Date | Dec-31-2014 |
| Min Price | $1.44 |
| Max Date | Dec-29-2017 |
| Max Price | $30.40 |
| Total Return | 1,442.94% |
| Annualized Return | 31.18% |
| Current Value of $1,000 Purchase | $15,429 |
| Number Returns | 7,260 |
| Average Return | 161.48% |
| Number Profitable Returns | 4,888 |
| Percent Profitable Returns | 67.33% |
| Number Unprofitable Returns | 2,372 |
| Percent Unprofitable Returns | 32.67% |
| Profitable to Unprofitable Returns Ratio | 2.06 |
| EXEL Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | 15.550 | Price to Sales | 19.16 |
| Earnings per Share | $0.0000 |
| PE Ratio | 429380000 |
| PE to Growth Ratio | 22.61 |
| Price to Book | 3.715 |
| PRICE DATA | |
| 52 Week High | $0.541 |
| 52 Week Low | $27.83 |
| Analyst Target Price | $0.356 |
| 50-Day Moving Average | $18.64 |
| 200-Day Moving Average | $26.1 |
| FINANCIAL DATA | |
| Revenue per Share | $1.16 |
| Revenue | $0 |
| Profit Margin | 664% |
| Return on Equity | 8.51% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
EXEL Compare Returns with S&P 500
EXEL Trendline Chart
EXEL Moving Average Chart
EXEL Stock Return Map - See Patterns of Gains and Losses
EXEL Stock Returns/Purchase Dates